摘要 |
The present invention relates to piperazine of formula (I) wherein R represents halogen, C<SUB>1-4 </SUB>alkyl, trifluoromethoxy or trifluoromethyl; R<SUB>1 </SUB>is trifluoromethyl, C<SUB>1-4 </SUB>alkyl, C<SUB>1-4 </SUB>alkoxy, halogen or trifluoromethoxy; R<SUB>2 </SUB>is hydrogen, C<SUB>1-4 </SUB>alkyl or C<SUB>2-6 </SUB>alkenyl; R<SUB>3 </SUB>represents hydrogen or C<SUB>1-4 </SUB>alkyl; n and m are independently 0 or an integer from 1 to 3; and pharmaceutically acceptable salts and solvates thereof, process for their preparation and their use in the treatment of condition mediated by tachykinins and/or by selective inhibition of the serotonin reuptake transporter protein.
|